Reliability and validity of the Turkish version of the Barthel Index-dyspnea in patients with pulmonary hypertension
Turkish Journal of Medical Sciences · 16.06.2026 · 56 (3) · 794-800
DOI: 10.55730/1300-0144.6213 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 16.06.2026. Verfasst von Pınar Merç und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiopulmonary Physiotherapy and Rehabilitation, Gülhane Faculty of Physiotherapy and Rehabilitation, University of Health Sciences, A…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Dyspnea, Activities of Daily Living, Severity of Illness Index. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: The Barthel Index-dyspnea (BI-d) is a respiratory disease-specific tool developed on the basis of the Barthel Index (BI), which provides a simple and quick way to measure the degree of dyspnea in activities of daily living (ADL). Dyspnea is one of the most common symptoms of pulmonary hypertension (PH). The objective of this study was to explore the reliability and validity of the Turkish version of the BI-d in patients with PH. Materials and methods: A total of 73 PH patients were included in the study. Criterion validity was explored using the modified Medical Research Council (mMRC) dyspnea scale, 6-min walk test (6MWT), and London Chest Activities of Daily Living (LCADL) scale, while divergent validity was examined through correlations between the BI-d and BI.
Results
The BI-d demonstrated strong correlations with the LCADL (r = 0.801) and mMRC (r = 0.775), and a moderately negative correlation with the 6MWD (r = –0.510), supporting criterion-related validity. A weak negative correlation with the BI (r = –0.289) supported divergent validity. The BI-d scores differed significantly across the mMRC grades and PH functional classes, confirming known-group validity. Reliability analyses showed good internal consistency (Cronbach’s α = 0.85) and excellent test–retest reliability (intraclass correlation coefficient = 0.94).
Conclusion
The Turkish version of the BI-d demonstrates high reliability and validity in PH. As a tool that integrates respiratory burden with activity-related functional performance, it provides a practical assessment of dyspnea-related impairment during ADL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiopulmonary Physiotherapy and Rehabilitation, Gülhane Faculty of Physiotherapy and Rehabilitation, University of Health Sciences, Ankara, Turkiye.
- Department of Cardiology, Cardiology Institute, İstanbul University-Cerrahpaşa, İstanbul, Turkiye.
- Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, İzmir Bakırçay University, İzmir, Turkiye.
- Department of Therapy and Rehabilitation, Vocational School of Health Services, Giresun University, Giresun, Turkiye.
ORCID-Profile: Pınar Merç, Rengin Demir, Melih Zeren, Habibe Durdu, Ümit Yaşar Sinan, Mehmet Serdar Küçükoğlu
Zitieren
APA
Merç, P., Demir, R., Zeren, M., Durdu, H., Sinan, Ü. Y., & Küçükoğlu, M. S. (2026). Reliability and validity of the Turkish version of the Barthel Index-dyspnea in patients with pulmonary hypertension. Turkish Journal of Medical Sciences, 56(3), 794-800. https://doi.org/10.55730/1300-0144.6213
Vancouver
Merç P, Demir R, Zeren M, Durdu H, Sinan ÜY, Küçükoğlu MS. Reliability and validity of the Turkish version of the Barthel Index-dyspnea in patients with pulmonary hypertension. Turkish Journal of Medical Sciences. 2026;56(3):794-800. doi:10.55730/1300-0144.6213
BibTeX
@article{Mer2026,
author = {Merç, Pınar and Demir, Rengin and Zeren, Melih and Durdu, Habibe and Sinan, Ümit Yaşar and Küçükoğlu, Mehmet Serdar},
title = {Reliability and validity of the Turkish version of the Barthel Index-dyspnea in patients with pulmonary hypertension},
journal = {Turkish Journal of Medical Sciences},
year = {2026},
volume = {56},
number = {3},
pages = {794--800},
doi = {10.55730/1300-0144.6213}
}
EUVIMED